A. Dondorp, F. Nosten, K. Stepniewska, N. Day, and N. White, South-East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group: Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial, Lancet, vol.366, pp.717-735, 2005.

A. Dondorp, C. Fanello, I. Hendriksen, E. Gomes, A. Seni et al., Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial, The Lancet, vol.376, issue.9753, pp.1647-1657, 2010.
DOI : 10.1016/S0140-6736(10)61924-1

H. Noedl, Y. Se, K. Schaecher, B. Smith, D. Socheat et al., Evidence of Artemisinin-Resistant Malaria in Western Cambodia, New England Journal of Medicine, vol.359, issue.24, pp.2619-2620, 2008.
DOI : 10.1056/NEJMc0805011

A. Dondorp, F. Nosten, P. Yi, D. Das, A. Phyo et al., Malaria, New England Journal of Medicine, vol.361, issue.5, pp.455-467, 2009.
DOI : 10.1056/NEJMoa0808859
URL : https://hal.archives-ouvertes.fr/hal-01199794

C. Amaratunga, S. Sreng, S. Suon, E. Phelps, K. Stepniewska et al., Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study, The Lancet Infectious Diseases, vol.12, issue.11, pp.851-858, 2012.
DOI : 10.1016/S1473-3099(12)70181-0

N. White, Preventing antimalarial drug resistance through combinations, Drug Resistance Updates, vol.1, issue.1, pp.3-9, 2001.
DOI : 10.1016/S1368-7646(98)80208-2

P. Guttmann and P. Ehrlich, Ueber die wirkung des methylenblau bei malaria, Berlin Klin Wochenschr, vol.1891, issue.28, pp.953-956

M. Akoachere, K. Buchholz, E. Fischer, J. Burhenne, W. Haefeli et al., In Vitro Assessment of Methylene Blue on Chloroquine-Sensitive and -Resistant Plasmodium falciparum Strains Reveals Synergistic Action with Artemisinins, Antimicrobial Agents and Chemotherapy, vol.49, issue.11, pp.4592-4597, 2005.
DOI : 10.1128/AAC.49.11.4592-4597.2005

O. Ademowo, C. Nneji, and A. Adedapo, In vitro antimalarial activity of methylene blue against field isolates of Plasmodium falciparum from children in Southwest Nigeria, Indian J Med Res, vol.126, pp.45-49, 2007.

J. Okombo, S. Kiara, L. Mwai, L. Pole, E. Ohuma et al., Baseline In Vitro Activities of the Antimalarials Pyronaridine and Methylene Blue against Plasmodium falciparum Isolates from Kenya, Antimicrobial Agents and Chemotherapy, vol.56, issue.2, pp.1105-1107, 2012.
DOI : 10.1128/AAC.05454-11

H. Atamna, M. Krugliak, G. Shalmiev, E. Deharo, G. Pescarmona et al., Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P. vinckei petteri and P. yoelii nigeriensis in vivo, Biochemical Pharmacology, vol.51, issue.5, pp.693-700, 1996.
DOI : 10.1016/S0006-2952(95)02258-9

G. Garavito, S. Bertani, M. Quiliano, A. Valentin, I. Aldana et al., The in vivo antimalarial activity of methylene blue combined with pyrimethamine, chloroquine and quinine, Mem??rias do Instituto Oswaldo Cruz, vol.107, issue.6, pp.820-823, 2012.
DOI : 10.1590/S0074-02762012000600019

A. Pascual, M. Henry, S. Briolant, S. Charras, E. Baret et al., In Vitro Activity of Proveblue (Methylene Blue) on Plasmodium falciparum Strains Resistant to Standard Antimalarial Drugs, vitro activity of Proveblue (Methylene Blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs, pp.2472-2474, 2011.
DOI : 10.1128/AAC.01466-10

J. Dormoi, A. Pascual, S. Briolant, R. Amalvict, S. Charras et al., Proveblue (Methylene Blue) as an Antimalarial Agent: In Vitro Synergy with Dihydroartemisinin and Atorvastatin, Antimicrobial Agents and Chemotherapy, vol.56, issue.6, pp.3467-3469, 2012.
DOI : 10.1128/AAC.06073-11

B. Pradines, M. Torrentino-madamet, A. Fontaine, M. Henry, E. Baret et al., Atorvastatin Is 10-Fold More Active In Vitro than Other Statins against Plasmodium falciparum, Antimicrobial Agents and Chemotherapy, vol.51, issue.7, pp.2654-2655, 2007.
DOI : 10.1128/AAC.01330-06

V. Parquet, S. Briolant, M. Torrentino-madamet, M. Henry, L. Almeras et al., Atorvastatin Is a Promising Partner for Antimalarial Drugs in Treatment of Plasmodium falciparum Malaria, Antimicrobial Agents and Chemotherapy, vol.53, issue.6, pp.2248-2252, 2009.
DOI : 10.1128/AAC.01462-08

N. Wurtz, S. Briolant, M. Gil, V. Parquet, M. Henry et al., Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene, Journal of Antimicrobial Chemotherapy, vol.65, issue.7, pp.1387-1394, 2010.
DOI : 10.1093/jac/dkq173

V. Parquet, M. Henry, N. Wurtz, J. Dormoi, S. Briolant et al., Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum, Malaria Journal, vol.9, issue.1, p.139, 2010.
DOI : 10.1186/1475-2875-9-139

H. Savini, J. Souraud, S. Briolant, E. Baret, R. Amalvict et al., Atorvastatin as a Potential Antimalarial Drug: In Vitro Synergy in Combinational Therapy with Dihydroartemisinin, Antimicrobial Agents and Chemotherapy, vol.54, issue.2, pp.966-967, 2010.
DOI : 10.1128/AAC.01006-09

V. Borek-dohalsky, J. Huclova, B. Barrett, B. Nemec, I. Ulc et al., Validated HPLC???MS???MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma???pharmacokinetic study, Analytical and Bioanalytical Chemistry, vol.35, issue.2, pp.275-285, 2006.
DOI : 10.1007/s00216-006-0655-3

A. Bienvenu and S. Picot, Statins Alone Are Ineffective in Cerebral Malaria but Potentiate Artesunate, Antimicrobial Agents and Chemotherapy, vol.52, issue.11, pp.4203-4204, 2008.
DOI : 10.1128/AAC.00513-08

J. Souraud, S. Briolant, J. Dormoi, J. Mosnier, H. Savini et al., Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model, Malaria Journal, vol.11, issue.1, p.13, 2012.
DOI : 10.1056/NEJMoa0808859
URL : https://hal.archives-ouvertes.fr/pasteur-00836498

J. Lou, R. Lucas, and G. Grau, Pathogenesis of Cerebral Malaria: Recent Experimental Data and Possible Applications for Humans, Clinical Microbiology Reviews, vol.14, issue.4, pp.810-820, 2001.
DOI : 10.1128/CMR.14.4.810-820.2001

N. Delahaye, N. Coltel, D. Puthier, M. Barbier, P. Benech et al., Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice, BMC Genomics, vol.8, issue.1, p.452, 2007.
DOI : 10.1186/1471-2164-8-452

P. Lackner, R. Beer, V. Heussler, G. Goebel, D. Rudzki et al., Behavioural and histopathological alterations in mice with cerebral malaria, Neuropathology and Applied Neurobiology, vol.50, issue.2, pp.177-188, 2006.
DOI : 10.1136/jnnp.69.4.433

A. Helmers, D. Gowda, K. Kain, and W. Liles, Statins Fail to Improve Outcome in Experimental Cerebral Malaria and Potentiate Toll-Like Receptor-Mediated Cytokine Production by Murine Macrophages, American Journal of Tropical Medicine and Hygiene, vol.81, issue.4
DOI : 10.4269/ajtmh.2009.09-0204

R. Kobbe, N. Schreiber, M. J. Jacobs, and T. , Simvastatin Treatment Shows No Effect on the Incidence of Cerebral Malaria or Parasitemia during Experimental Malaria, Antimicrobial Agents and Chemotherapy, vol.52, issue.4, pp.1583-1584, 2008.
DOI : 10.1128/AAC.01428-07

P. Lackner, R. Beer, R. Helbok, G. Broessner, K. Engelhardt et al., Scanning electron microscopy of the neuropathology of murine cerebral malaria, Malaria Journal, vol.5, issue.1, p.116, 2006.
DOI : 10.1186/1475-2875-5-116

N. White, G. Turner, I. Medana, A. Dondorp, and N. Day, The murine cerebral malaria phenomenon, Trends in Parasitology, vol.26, issue.1, pp.11-15, 2010.
DOI : 10.1016/j.pt.2009.10.007

Z. Taoufiq, P. Pino, N. Dilimabaka, N. Arrouss, I. Assi et al., Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage, Malaria Journal, vol.10, issue.1, p.52, 2011.
DOI : 10.1016/j.exppara.2010.01.005
URL : https://hal.archives-ouvertes.fr/inserm-00663669

P. Reis, V. Estato, T. Da-silva, D. Avila, J. Siqueira et al., Statins Decrease Neuroinflammation and Prevent Cognitive Impairment after Cerebral Malaria, PLoS Pathogens, vol.233, issue.12, p.1003099, 2012.
DOI : 10.1371/journal.ppat.1003099.s007

B. Coulibaly, A. Zoungrana, F. Mockenhaupt, R. Schirmer, C. Klose et al., Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial, PLoS ONE, vol.49, issue.2, p.5318, 2009.
DOI : 10.1371/journal.pone.0005318.s002

P. Meissner, G. Mandi, B. Coulibaly, S. Witte, T. Tapsoba et al., Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine, Malaria Journal, vol.5, issue.1, p.84, 2006.
DOI : 10.1186/1475-2875-5-84

S. Adjalley, G. Johnston, T. Li, R. Eastman, E. Ekland et al., Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue, Proceedings of the National Academy of Sciences, vol.108, issue.47, pp.1214-1223, 2011.
DOI : 10.1073/pnas.1112037108

J. Lelièvre, M. Almeda, S. Lozano, C. Miguel, V. Franco et al., Activity of Clinically Relevant Antimalarial Drugs on Plasmodium falciparum Mature Gametocytes in an ATP Bioluminescence ???Transmission Blocking??? Assay, PLoS ONE, vol.16, issue.4, p.35019, 2012.
DOI : 10.1371/journal.pone.0035019.t002

D. Kasozi, S. Gromer, H. Adler, K. Zocher, S. Rahlfs et al., The bacterial redox signaller pyocyanin as an antiplasmodial agent: comparisons with its thioanalog methylene blue, Redox Report, vol.86, issue.4, pp.154-165, 2011.
DOI : 10.1186/1475-2875-7-45

C. Peatey, D. Leroy, D. Gardiner, and K. Trenholme, Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?, Malaria Journal, vol.11, issue.1, p.34, 2012.
DOI : 10.1371/journal.pone.0005318
URL : http://doi.org/10.1186/1475-2875-11-34

M. Anthony, J. Burrows, S. Duparc, J. Moehrle, and T. Wells, The global pipeline of new medicines for the control and elimination of malaria, Malaria Journal, vol.11, issue.1, p.316, 2012.
DOI : 10.1038/clpt.2009.51